National Health Investors, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | $0.68 | $0.68 | $0.68 |
Q2 2024 | 2 | $0.72 | $0.72 | $0.72 |
Q3 2024 | 3 | $0.73 | $0.73 | $0.73 |
Q4 2024 | 5 | $0.74 | $0.78 | $0.75 |
Q1 2025 | 3 | $0.72 | $0.76 | $0.75 |
Q2 2025 | 2 | $0.71 | $0.91 | $0.79 |
Q3 2025 | 2 | $0.72 | $0.93 | $0.80 |
Q4 2025 | 2 | $0.73 | $0.93 | $0.81 |
Q1 2026 | 1 | $0.73 | $0.93 | $0.81 |
Q2 2026 | 1 | $0.74 | $0.94 | $0.82 |
Q3 2026 | 1 | $0.74 | $0.95 | $0.82 |
Q4 2026 | 1 | $0.75 | $0.96 | $0.83 |
National Health Investors, Inc. Earnings Date And Information
National Health Investors, Inc. last posted its earnings results on Tuesday, November 5th, 2024. The company reported $1.03 earnings per share for the quarter, missing analysts' consensus estimates of $1.07 by $0.04. The company had revenue of 69.17 M for the quarter and had revenue of 319.84 M for the year. National Health Investors, Inc. has generated $3 earnings per share over the last year ($3.13 diluted earnings per share) and currently has a price-to-earnings ratio of 26.66. National Health Investors, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based on prior year's report dates.
National Health Investors, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/05/2024 | Q3 2024 | $1.07 | $0.66 | -0.41 | $67.93 M | $69.17 M |
08/06/2024 | Q2 2024 | $1.10 | $0.81 | -0.29 | $64.95 M | $85.69 M |
05/06/2024 | Q1 2024 | $1.05 | $0.71 | -0.34 | $82.24 M | |
02/26/2024 | Q4 2023 | $0.74 | $79.47 M | |||
11/07/2023 | Q3 2023 | $1.08 | $0.68 | -0.4 | $62.58 M | $80.11 M |
08/08/2023 | Q2 2023 | $0.69 | $0.92 | 0.23 | $58.86 M | $77.88 M |
05/09/2023 | Q1 2023 | $0.99 | $0.18 | -0.81 | $82.39 M | |
02/27/2023 | Q4 2022 | -$0.24 | $70.67 M | |||
11/08/2022 | Q3 2022 | $0.77 | $0.78 | 0.01 | $62.49 M | $76.30 M |
08/08/2022 | Q2 2022 | $1.21 | $0.25 | -0.96 | $65.74 M | $59.90 M |
05/09/2022 | Q1 2022 | $1.17 | -$0.03 | -1.2 | $71.33 M | |
02/22/2022 | Q4 2021 | $1.05 | $0.14 | -0.91 | $69.67 M | |
11/08/2021 | Q3 2021 | $1.18 | $0.67 | -0.51 | $68.95 M | $73.83 M |
08/09/2021 | Q2 2021 | $0.90 | $0.85 | -0.05 | $71.59 M | $74.33 M |
05/10/2021 | Q1 2021 | $1.30 | $0.78 | -0.52 | $80.89 M | |
02/22/2021 | Q4 2020 | $1.36 | $0.83 | -0.53 | $81.24 M | |
11/09/2020 | Q3 2020 | $1.43 | $0.95 | -0.48 | $75.04 M | $84.30 M |
08/10/2020 | Q2 2020 | $1.43 | $0.99 | -0.44 | $76.96 M | $84.17 M |
05/11/2020 | Q1 2020 | $0.95 | $1.37 | 0.42 | $83.08 M | |
02/19/2020 | Q4 2019 | $1.41 | $0.95 | -0.46 | $82.19 M |
National Health Investors, Inc. Earnings: Frequently Asked Questions
-
When is National Health Investors, Inc.'s earnings date?
National Health Investors, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates.
-
How can I listen to National Health Investors, Inc.'s earnings conference call?
The conference call for National Health Investors, Inc.'s latest earnings report can be listened to online.
-
How can I read National Health Investors, Inc.'s conference call transcript?
The conference call transcript for National Health Investors, Inc.'s latest earnings report can be read online.
-
How much revenue does National Health Investors, Inc. generate each year?
National Health Investors, Inc. (:NHI) has a recorded annual revenue of $319.84 M.
-
How much profit does National Health Investors, Inc. generate each year?
National Health Investors, Inc. (:NHI) has a recorded net income of $319.84 M. National Health Investors, Inc. has generated $3.13 earnings per share over the last four quarters.
-
What is National Health Investors, Inc.'s price-to-earnings ratio?
National Health Investors, Inc. (:NHI) has a price-to-earnings ratio of 26.66 and price/earnings-to-growth ratio is -39.19.